Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer

Status unconfirmed · Phase 1

Conditions studied: Prostate Cancer

In brief

The purpose of this trial is to evaluate a short course of very focused (stereotactic) external beam radiation therapy for the treatment of early stage prostate cancer. The investigators will gather scientific information about the tolerance and side effects this type of radiation. The investigators will then compare these results with those of standard 8 week course of external beam radiation therapy to see if this study treatment is equally or more effective in treating prostate cancer.

Key facts

Study ID

NCT00969202

Run by

San Diego Radiosurgery

People needed

50

Starts

2009-08-01

Expected to finish

2016-12-01

Last updated by the study team

2015-11-18

Who can join

Age: 18 and older, up to 99. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed adenocarcinoma of the prostate
• Gleason score ≤ 6 and low volume Gleason 7 (3+4)
• PSA < 10
• Clinical Stage of T2a or less
• Ability to understand and the willingness to sign a written informed consent document

You may not qualify if…

• Prior radiation treatment for prostate cancer
• Gleason score > 7
• PSA > 10
• Clinical Stage of T2b or greater

Where it is running

• San Diego Radiosurgery at Palomar Medical Center — Escondido, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.